Article
Inhibition of IFITM3 in cerebrovascular endothelium alleviates Alzheimer's-related phenotypes.
Alzheimer's & dementia : the journal of the Alzheimer's Association - 1 Feb 2025
Feng Yijia, Wang Shengya, Yang Danlu, Zheng Wu, Xia Huwei, Zhu Qinxin, Wang Zhipeng, Hu Bolang, Jiang Xinyi, Qin Xuemei, Ni Chenkang, Pan Wenhao, Zhao Yifan, Pan Sipei, Zhang Yun, Song Weihong
Abstract excerpt
INTRODUCTION: Interferon-induced transmembrane protein 3 (IFITM3) modulates γ-secretase in Alzheimer's Disease (AD). Although IFITM3 knockout reduces amyloid β protein (Aβ) production, its cell-specific effect on AD remains unclear. METHODS: Single nucleus RNA sequencing (snRNA-seq) was used to assess IFITM3 expression. Adeno-associated virus-BI30 (AAV-BI30) was injected to reduce IFITM3 expression in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
